5,461 reports of this reaction
2.4% of all TERIPARATIDE reports
#11 most reported adverse reaction
HEADACHE is the #11 most commonly reported adverse reaction for TERIPARATIDE, manufactured by Eli Lilly and Company. There are 5,461 FDA adverse event reports linking TERIPARATIDE to HEADACHE. This represents approximately 2.4% of all 227,333 adverse event reports for this drug.
TERIPARATIDE has an overall safety score of 78 out of 100. Patients taking TERIPARATIDE who experience headache should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HEADACHE is a less commonly reported adverse event for TERIPARATIDE, but still significant enough to appear in the safety profile.
In addition to headache, the following adverse reactions have been reported for TERIPARATIDE:
The following drugs have also been linked to headache in FDA adverse event reports:
HEADACHE has been reported as an adverse event in 5,461 FDA reports for TERIPARATIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
HEADACHE accounts for approximately 2.4% of all adverse event reports for TERIPARATIDE, making it a notable side effect.
If you experience headache while taking TERIPARATIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.